申请人:Takeda Pharmaceutical Company Limited
公开号:EP1500658A1
公开(公告)日:2005-01-26
The present invention provides a novel thiol derivative [I] which has an excellent matrix metalloprotease inhibiting activity and is useful as a pharmaceutical composition, particularly a therapeutic agent or prophylactic agent for osteoarthritis and rheumatoid arthritis and a salt thereof, the thiol derivative being a compound represented by the formula [I]:
wherein ring A represents an optionally substituted aromatic heterocyclic ring;
ring B represents an optionally substituted homocyclic or heterocyclic ring;
R1 represents a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group, an optionally substituted heterocyclic group or SR2 (wherein R2 represents a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group);
X represents an optionally substituted divalent C1-3 aliphatic hydrocarbon group;
Y represents an optionally substituted hydrocarbon group, a halogen atom, a carboxy group, an acyl group, an optionally substituted hydroxy group, an optionally substituted amino group, SR3 (wherein R3 represents a hydrogen atom, an optionally substituted hydrocarbon group, an acyl group or an optionally substituted heterocyclic group), an oxo group, a thioxo group, an optionally substituted imino group, a nitro group or a cyano group; and
q represents an integer of 0 to 5.
本发明提供了一种新型硫醇衍生物[I],它具有优异的基质金属蛋白酶抑制活性,可用作药物组合物,特别是骨关节炎和类风湿性关节炎的治疗剂或预防剂及其盐,该硫醇衍生物是由式[I]代表的化合物:
其中环 A 代表任选取代的芳香杂环;
环 B 代表任选取代的同环或杂环;
R1 代表氢原子、任选取代的烃基、酰基、任选取代的杂环基团或 SR2(其中 R2 代表氢原子、任选取代的烃基、酰基或任选取代的杂环基团);
X 代表任选取代的二价 C1-3 脂肪族烃基;
Y 代表任选取代的烃基、卤素原子、羧基、酰基、任选取代的羟基、任选取代的氨基、SR3(其中 R3 代表氢原子、任选取代的烃基、酰基或任选取代的杂环基)、氧代基团、硫代基团、任选取代的亚氨基、硝基或氰基;以及
q 代表 0 至 5 的整数。